Brian Weinert

Dr Brian Weinert is a Principal Scientist and Discovery Project Lead at Nykode Therapeutics, where he works on the development of novel cancer immunotherapies, including neoantigen vaccine platforms. He has extensive experience in proteomics and molecular biology, with previous roles spanning academia and industry, including positions at the University of Copenhagen, IO Biotech, and Encodia. His research focuses on applying advanced analytical and multi-omics approaches to understand immune responses and support the discovery of next-generation therapeutic vaccines.